2,182
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Nuclear Magnetic Resonance Structure-Based Drug Design

&
Pages 2373-2376 | Received 04 May 2018, Accepted 08 Aug 2018, Published online: 16 Oct 2018

References

  • Redecke L Nass K Deponte DP et al. Natively inhibited Trypanosoma brucei cathepsin B structure determined by using an X-ray laser. Science339 (6116), 227 – 230 (2013).
  • Wong W Bai XC Sleebs BE et al. Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat. Microbiol.2, 17031 (2017).
  • Gossert AD Jahnke W . NMR in drug discovery: a practical guide to identification and validation of ligands interacting with biological macromolecules. Prog. Nucl. Magn. Reson. Spectrosc.97, 82 – 125 (2016).
  • Orts J Walti MA Marsh M et al. NMR-based determination of the 3D structure of the ligand-protein interaction site without protein resonance assignment. J. Am. Chem. Soc.138 (13), 4393 – 4400 (2016).
  • Constantine KL Davis ME Metzler WJ Mueller L Claus BL . Protein–ligand NOE matching: a high-throughput method for binding pose evaluation that does not require protein NMR resonance assignments. J. Am. Chem. Soc.128 (22), 7252 – 7263 (2006).
  • Mccoy MA Wyss DF . Alignment of weakly interacting molecules to protein surfaces using simulations of chemical shift perturbations. J. Biomol. NMR18 (3), 189 – 198 (2000).
  • Cioffi M Hunter CA Packer MJ Pandya MJ Williamson MP . Use of quantitative (1)H NMR chemical shift changes for ligand docking into barnase. J. Biomol. NMR43 (1), 11 – 19 (2009).
  • Williamson MP . Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Magn. Reson. Spectrosc.73, 1 – 16 (2013).
  • Otting G . Prospects for lanthanides in structural biology by NMR. J. Biomol. NMR42 (1), 1 – 9 (2008).
  • Schieborr U Vogtherr M Elshorst B et al. How much NMR data is required to determine a protein-ligand complex structure? Chembiochem 6 (10), 1891 – 1898 (2005).
  • Stratmann D Boelens R Bonvin AMJJ . Quantitative use of chemical shifts for the modeling of protein complexes. Proteins79 (9), 2662 – 2670 (2011).
  • Pintacuda G Park AY Keniry MA Dixon NE Otting G . Lanthanide labeling offers fast NMR approach to 3D structure determinations of protein-protein complexes. J. Am. Chem. Soc.128 (11), 3696 – 3702 (2006).
  • Sanchez-Pedregal VM Reese M Meiler J Blommers MJJ Griesinger C Carlomagno T . The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. Angew. Chem. Int. Ed. Engl.44 (27), 4172 – 4175 (2005).
  • Hajduk PJ Mack JC Olejniczak ET Park C Dandliker PJ Beutel BA . SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. J. Am. Chem. Soc.126 (8), 2390 – 2398 (2004).
  • Moseley HN Curto EV Krishna NR . Complete relaxation and conformational exchange matrix (CORCEMA) analysis of NOESY spectra of interacting systems; two-dimensional transferred NOESY. J. Magn. Reson B108 (3), 243 – 261 (1995).
  • Ni F . Recent developments in transferred NOE methods. Prog. Nucl. Mag. Res. Sp.26, 517 – 606 (1994).
  • Tugarinov V Kanelis V Kay LE . Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy. Nat. Protoc.1 (2), 749 – 754 (2006).
  • Breeze AL . Isotope-filtered NMR methods for the study of biomolecular structure and interactions. Prog. Nucl. Mag. Res. Sp.36 (4), 323 – 372 (2000).
  • Dominguez C Boelens R Bonvin AM . HADDOCK: a protein–protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc.125 (7), 1731 – 1737 (2003).
  • Grishaev A Llinas M . CLOUDS, a protocol for deriving a molecular proton density via NMR (vol 99, pg 6707, 2002). Proc. Natl Acad. Sci. USA99 (16), 10941 – 10941 (2002).